Compare ICCC & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICCC | LOAN |
|---|---|---|
| Founded | 1982 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.5M | 51.9M |
| IPO Year | 1987 | 1999 |
| Metric | ICCC | LOAN |
|---|---|---|
| Price | $5.57 | $4.87 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 20.0K | ★ 39.9K |
| Earning Date | 11-13-2025 | 10-24-2025 |
| Dividend Yield | N/A | ★ 9.87% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.26 | ★ 0.46 |
| Revenue | ★ $27,769,304.00 | $7,138,128.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.47 |
| P/E Ratio | $21.85 | ★ $10.07 |
| Revenue Growth | ★ 16.49 | N/A |
| 52 Week Low | $4.28 | $4.29 |
| 52 Week High | $7.60 | $6.05 |
| Indicator | ICCC | LOAN |
|---|---|---|
| Relative Strength Index (RSI) | 53.46 | 55.85 |
| Support Level | $4.72 | $4.64 |
| Resistance Level | $5.36 | $4.83 |
| Average True Range (ATR) | 0.31 | 0.14 |
| MACD | 0.12 | 0.05 |
| Stochastic Oscillator | 77.73 | 96.67 |
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.